DNAprint Genomics (DNAG)

[gunnabeoneday]

Ming (and others):

Ming, when speaking of NIH grants, you stated: "I also think that there is a misconception about just how far ahead we potentially are"

Great point and one that has confused me as well.

It's confused me not so much with NIH grants, but with outside collaborations with large pharma's, etc. Why hasn't anybody stepped up and partnered with us and confirmed that our intellectual property is the best around and that little ole DNAP could help THEIR CAUSE???

If we are indeed as far ahead as we think, then why haven't we inked more collaborations than the cosmetic deal?? Surely our value proposition has to be recognized by such companies who would stand to benefit immensly from getting more products to market, much quicker, and for less $$$.

Why wouldn't anybody step up when we were seeking funding?? Surely, they could have gotten a better deal than LJC since they also would bring value to the table, no? IMO, such companies would throw $8-15M at this and not blink an eye based on the potential payback for them.

The Orchid/BC option has been mentioned as a potential hinderance. But, I thought by partnering with such companies and having them contract us for a fee ($200,000+) to perform the analysis and hopeful discovery, that "the option" agreement would not be applicable......

I'm long DNAP but just trying to sort some issues out.

I appreciate all input. Tia.